<h1>AstraZeneca Halts lb450M Vaccine Plant Expansion in England Due to Reduced Government Funding; No Job Losses Expected.</h1> AstraZeneca has canceled its plan to invest 450 million pounds in expanding a vaccine manufacturing plant in northwest England, citing reduced financial support from the new Labour government compared to the previous Conservative administration. This decision undermines the government's efforts to enhance economic growth and attract international investment. Despite the cancellation, the existing facility will continue to operate without job losses. The government attributed the withdrawal to changes in AstraZeneca's investment proposal, though specific details were not disclosed. The prior administration had anticipated the investment would benefit the UK's life sciences sector and pandemic preparedness.